CompletedPhase 4

Changes in Iron Markers Following Iron Loading in Hemodialysis Patients

Greece160 participantsStarted 2005-09

Plain-language summary

The purpose of this study is to describe alterations of serum ferritin, transferrin saturation, soluble transferrin receptor, % hypochromic erythrocytes, % reticulocytes, reticulocyte hemoglobin content after iron loading in hemodialysis patients.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * hemodialysis for three months minimum * stable epoetin dose for two months minimum * serum ferritin concentration \< 1000 ng/ml * transferrin saturation \< 50% * parathormone concentration \< 800 pg/ml Exclusion Criteria: * hemoglobin concentration \> 13g/dl * serum ferritin concentration \< 20 ng/ml * vitamin B12 and/or folic deficiency * other hematologic disease than anemia * cancer * hypothyroidism * infectious disease

What they're measuring

Ferritin alterations after iron loading at six and twelve weeks from the beginning of iron loading.

Trial details

NCT IDNCT00308490

SponsorPapageorgiou General Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

View on ClinicalTrials.gov More Anemia in Chronic Renal Disease trials